Pregabalin Completed Phase 1 Trials for Peripheral Nueropathy Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02783183A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin